These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 17094424)

  • 1. High-dose-rate interstitial brachytherapy for mobile tongue cancer: influence of the non-irradiated period.
    Kakimoto N; Inoue T; Inoue T; Murakami S; Furukawa S; Yoshida K; Yoshioka Y; Yamazaki H; Tanaka E; Shimizutani K
    Anticancer Res; 2006; 26(5B):3933-7. PubMed ID: 17094424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interstitial high-dose-rate brachytherapy combined with cervical dissection on head and neck cancer.
    Pellizzon AC; dos Santos Novaes PE; Conte Maia MA; Ferrigno R; Fogarolli R; Salvajoli JV; Kowalski LP
    Head Neck; 2005 Dec; 27(12):1035-41. PubMed ID: 16114005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic results for 100 patients with cancer of the mobile tongue treated with low dose rate interstitial irradiation.
    Kobayashi Y; Karasawa K; Komiya Y; Hanyu N; Okamoto M; Chang TC; Kiguchi Y; Uchida I; Yoshida S; Asoda S
    Anticancer Res; 2007; 27(3B):1689-92. PubMed ID: 17595798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perioperative high-dose-rate brachytherapy (PHDRB) in previously irradiated head and neck cancer: Initial results of a Phase I/II reirradiation study.
    Martínez-Monge R; Alcalde J; Concejo C; Cambeiro M; Garrán C
    Brachytherapy; 2006; 5(1):32-40. PubMed ID: 16563995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose rate interstitial brachytherapy for mobile tongue cancer: Part 2. Phase III trial of HDR versus LDR interstitial brachytherapy for T1-T2N0 carcinoma of the mobile tongue.
    Inoue T; Inoue T
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():291-5. PubMed ID: 10895169
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term functional outcome of brachytherapy for carcinoma of the mobile tongue: focus on the atrophic change of irradiated tongue.
    Urashima Y; Nakamura K; Shioyama Y; Sasaki T; Ohga S; Toba T; Kunitake N; Chikui T; Kawazu T; Yamada T; Terashima H; Honda H
    Jpn J Clin Oncol; 2006 Nov; 36(11):681-7. PubMed ID: 17020894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exclusive low-dose-rate brachytherapy in 279 patients with T2N0 mobile tongue carcinoma.
    Bourgier C; Coche-Déquéant B; Fournier C; Castelain B; Prévost B; Lefebvre JL; Lartigau E
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):434-40. PubMed ID: 16168836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of high-dose-rate interstitial brachytherapy in patients with oral tongue carcinoma.
    Guinot JL; Santos M; Tortajada MI; Carrascosa M; Estellés E; Vendrell JB; Muelas R; Chust ML; Mengual JL; Arribas L
    Brachytherapy; 2010; 9(3):227-34. PubMed ID: 20116340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose rate interstitial brachytherapy for mobile tongue cancer: Part 3. Comparative study of early mucosal reaction and late tongue atrophy between LDR and HDR Ir-192 interstitial brachytherapy for patients with carcinoma of the mobile tongue.
    Inoue T; Inoue T; Yoshioka Y; Yoshida K
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():296-300. PubMed ID: 10895170
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparison of brachytherapy and surgery for the treatment of stage I-II squamous cell carcinoma of the tongue.
    Umeda M; Komatsubara H; Ojima Y; Minamikawa T; Shibuya Y; Yokoo S; Ishii J; Komori T
    Int J Oral Maxillofac Surg; 2005 Oct; 34(7):739-44. PubMed ID: 15921890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose rate interstitial brachytherapy for stage I-II tongue cancer.
    Umeda M; Komatsubara H; Nishimatsu N; Yokoo S; Shibuya Y; Komori T
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Nov; 90(5):667-70. PubMed ID: 11077395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose-rate interstitial brachytherapy in recurrent and previously irradiated head and neck cancers--preliminary results.
    Narayana A; Cohen GN; Zaider M; Chan K; Lee N; Wong RJ; Boyle J; Shaha A; Kraus D; Shah J; Zelefsky MJ
    Brachytherapy; 2007; 6(2):157-63. PubMed ID: 17434110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of low- and high-dose-rate interstitial brachytherapy for T3 mobile tongue cancer.
    Kakimoto N; Inoue T; Inoue T; Murakami S; Furukawa S; Yoshida K; Yoshioka Y; Yamazaki H; Tanaka E; Shimizutani K
    Radiother Oncol; 2003 Aug; 68(2):123-8. PubMed ID: 12972306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High dose rate interstitial brachytherapy for mobile tongue cancer: Part 1. Phase I/II study of HDR hyperfractionated interstitial brachytherapy for oral cancer.
    Inoue T; Inoue T; Teshima T
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():287-90. PubMed ID: 10895168
    [No Abstract]   [Full Text] [Related]  

  • 15. High dose rate brachytherapy in the treatment of oral cancer--the preliminary one institution experience.
    Petera J; Dolezel M; Jirousek Z; Tucek L; Bedrosová J; Frgala T
    Neoplasma; 2006; 53(3):232-6. PubMed ID: 16652193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical evaluation based on cost-effectiveness].
    Inoue T; Inoue T
    Gan To Kagaku Ryoho; 1998 Jan; 25(1):13-9. PubMed ID: 9464324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of three major radioactive sources for brachytherapy used in the treatment of node negative T1-T3 oral tongue cancer: influence of age on outcome.
    Yamazaki H; Inoue T; Yoshida K; Yoshioka Y; Furukawa S; Kakimoto N; Shimizutani K
    Anticancer Res; 2007; 27(1B):491-7. PubMed ID: 17348432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal evaluation of patients with cancer in the oral tongue, tonsils, or base of tongue--does interstitial radiation dose affect quality of life?
    Petruson K; Mercke C; Lundberg LM; Silander E; Hammerlid E
    Brachytherapy; 2005; 4(4):271-7. PubMed ID: 16344257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interstitial brachytherapy and neck dissection for Stage III squamous cell carcinoma of the mobile tongue.
    Ihara N; Shibuya H; Yoshimura R; Oota S; Miura M; Watanabe H
    Acta Oncol; 2005; 44(7):709-16. PubMed ID: 16227161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of high-dose-rate and low-dose-rate brachytherapy in the treatment of endometrial carcinoma.
    Fayed A; Mutch DG; Rader JS; Gibb RK; Powell MA; Wright JD; Elnaqa I; Zoberi I; Grigsby PW
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):480-4. PubMed ID: 17141980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.